CURTEGA Trademark

Trademark Overview


On Monday, November 7, 2005, a trademark application was filed for CURTEGA with the United States Patent and Trademark Office. The USPTO has given the CURTEGA trademark a serial number of 78748657. The federal status of this trademark filing is ABANDONED - EXPRESS AFTER PUB as of Tuesday, May 22, 2007. This trademark is owned by Agouron Pharmaceuticals, Inc.. The CURTEGA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of macular degeneration, disorders of the eye, cardiovascular disease, central nervous system diseases and disorders, neurological disorders, urological disorders, urogenital disorders, gastrointestinal disorders, musculoskeletal disorders, allergies, diabetes, hypertension, erectile dysfunction, sexual dysfunction, premature ejaculation, stroke, cancer, migraines, pain, obesity, inflammation, inflammatory diseases, respiratory diseases, infectious diseases, immunological disorders, viral disorders and fungal disorders; pharmaceutical preparations namely, cholesterol preparations, smoking cessation preparations, dermatological preparations, gynecological preparations, osteoporosis preparations and ophthalmological preparations
curtega

General Information


Serial Number78748657
Word MarkCURTEGA
Filing DateMonday, November 7, 2005
Status605 - ABANDONED - EXPRESS AFTER PUB
Status DateTuesday, May 22, 2007
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 11, 2006

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of macular degeneration, disorders of the eye, cardiovascular disease, central nervous system diseases and disorders, neurological disorders, urological disorders, urogenital disorders, gastrointestinal disorders, musculoskeletal disorders, allergies, diabetes, hypertension, erectile dysfunction, sexual dysfunction, premature ejaculation, stroke, cancer, migraines, pain, obesity, inflammation, inflammatory diseases, respiratory diseases, infectious diseases, immunological disorders, viral disorders and fungal disorders; pharmaceutical preparations namely, cholesterol preparations, smoking cessation preparations, dermatological preparations, gynecological preparations, osteoporosis preparations and ophthalmological preparations

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code8 - Abandoned
Class Status DateTuesday, May 22, 2007
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAgouron Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Party NameAgouron Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Trademark Events


Event DateEvent Description
Tuesday, May 22, 2007ABANDONMENT NOTICE MAILED - AFTER PUBLICATION
Tuesday, May 22, 2007ABANDONMENT - AFTER PUBLICATION
Monday, May 21, 2007TEAS EXPRESS ABANDONMENT RECEIVED
Thursday, March 22, 2007EXTENSION 1 GRANTED
Thursday, March 22, 2007EXTENSION 1 FILED
Thursday, March 22, 2007TEAS EXTENSION RECEIVED
Tuesday, October 3, 2006NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 11, 2006PUBLISHED FOR OPPOSITION
Wednesday, June 21, 2006NOTICE OF PUBLICATION
Thursday, May 25, 2006LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, May 19, 2006ASSIGNED TO LIE
Friday, May 19, 2006ASSIGNED TO LIE
Thursday, May 11, 2006APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, May 11, 2006ASSIGNED TO EXAMINER
Monday, November 14, 2005NEW APPLICATION ENTERED IN TRAM